ATE90394T1 - Bestimmungstest fuer der thrombose verwandte materialien. - Google Patents
Bestimmungstest fuer der thrombose verwandte materialien.Info
- Publication number
- ATE90394T1 ATE90394T1 AT87302073T AT87302073T ATE90394T1 AT E90394 T1 ATE90394 T1 AT E90394T1 AT 87302073 T AT87302073 T AT 87302073T AT 87302073 T AT87302073 T AT 87302073T AT E90394 T1 ATE90394 T1 AT E90394T1
- Authority
- AT
- Austria
- Prior art keywords
- thrombosis
- determination test
- materials related
- plasma
- amt
- Prior art date
Links
- 208000007536 Thrombosis Diseases 0.000 title 1
- 102100033571 Tissue-type plasminogen activator Human genes 0.000 abstract 2
- 108050006955 Tissue-type plasminogen activator Proteins 0.000 abstract 2
- KWPACVJPAFGBEQ-IKGGRYGDSA-N (2s)-1-[(2r)-2-amino-3-phenylpropanoyl]-n-[(3s)-1-chloro-6-(diaminomethylideneamino)-2-oxohexan-3-yl]pyrrolidine-2-carboxamide Chemical compound C([C@@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)CCl)C1=CC=CC=C1 KWPACVJPAFGBEQ-IKGGRYGDSA-N 0.000 abstract 1
- 101000801481 Homo sapiens Tissue-type plasminogen activator Proteins 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- 239000003527 fibrinolytic agent Substances 0.000 abstract 1
- 230000003480 fibrinolytic effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000002537 thrombolytic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/972—Plasminogen activators
- G01N2333/9726—Tissue plasminogen activator
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Luminescent Compositions (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84012786A | 1986-03-12 | 1986-03-12 | |
| EP87302073A EP0237332B1 (de) | 1986-03-12 | 1987-03-11 | Bestimmungstest für der Thrombose verwandte Materialien |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE90394T1 true ATE90394T1 (de) | 1993-06-15 |
Family
ID=25281524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87302073T ATE90394T1 (de) | 1986-03-12 | 1987-03-11 | Bestimmungstest fuer der thrombose verwandte materialien. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0237332B1 (de) |
| AT (1) | ATE90394T1 (de) |
| AU (1) | AU602507B2 (de) |
| CA (1) | CA1313488C (de) |
| DE (1) | DE3786098T2 (de) |
| NZ (1) | NZ219559A (de) |
| ZA (1) | ZA871764B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5217705A (en) * | 1987-09-25 | 1993-06-08 | Neorx Corporation | Method of diagnosing blood clots using fibrin-binding proteins |
| NL8802710A (nl) * | 1988-11-04 | 1990-06-01 | Tno | Werkwijze voor het bepalen van een enzym en daarvoor geschikte kit en stof. |
| US5187069A (en) * | 1990-08-06 | 1993-02-16 | Henry Ford Health System | Active site labelling of plasminogen |
| EP2471945A1 (de) * | 2010-12-30 | 2012-07-04 | Siemens Healthcare Diagnostics Products GmbH | Verfahren zur Bestimmung von Inhibitoren der Gerinnung |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4318904A (en) * | 1980-04-25 | 1982-03-09 | Research Corporation | Peptide affinity labels for thrombin and other trypsin-like proteases |
| US4438209A (en) * | 1981-07-17 | 1984-03-20 | Mallinckrodt, Inc. | Radioimmunoassay for fibrinopeptide A |
-
1987
- 1987-02-17 CA CA000529939A patent/CA1313488C/en not_active Expired - Lifetime
- 1987-03-10 NZ NZ219559A patent/NZ219559A/en unknown
- 1987-03-10 AU AU69861/87A patent/AU602507B2/en not_active Expired
- 1987-03-11 ZA ZA871764A patent/ZA871764B/xx unknown
- 1987-03-11 AT AT87302073T patent/ATE90394T1/de not_active IP Right Cessation
- 1987-03-11 EP EP87302073A patent/EP0237332B1/de not_active Expired - Lifetime
- 1987-03-11 DE DE87302073T patent/DE3786098T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0237332B1 (de) | 1993-06-09 |
| EP0237332A1 (de) | 1987-09-16 |
| CA1313488C (en) | 1993-02-09 |
| AU602507B2 (en) | 1990-10-18 |
| DE3786098T2 (de) | 1993-12-16 |
| ZA871764B (en) | 1988-11-30 |
| AU6986187A (en) | 1987-09-17 |
| DE3786098D1 (de) | 1993-07-15 |
| NZ219559A (en) | 1990-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Andreasen et al. | Inactive proenzyme to tissue‐type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody. | |
| EP0420332A3 (en) | Method for determining the endogenous thrombin potential of plasma and blood, and also a kit or use in said method | |
| DK36991D0 (da) | Vaevsplasminoaktivator-(t-pa)-variant med zymogene eller fibrinspecifikke eller plasmakoagel-specifikke egenskaber, fremgangsmaade til fremstilling deraf, dna-sekvens, som koder for varianten, replicerbar udtrykkelsesvektor for denne og vaertsceller transformeret med vektoren | |
| EP0236985A3 (en) | Method for the photometric determination of protein c and/or protein s activity | |
| ATE62512T1 (de) | Verfahren zur bestimmung von plasminogenaktivatoren (pa). | |
| ATE90394T1 (de) | Bestimmungstest fuer der thrombose verwandte materialien. | |
| ES8605099A1 (es) | Procedimiento para la determinacion de monomero de fibrina en plasma | |
| DK30686A (da) | Fremgangsmaade til bestemmelse af plasmas fibrinolytiske tilstand | |
| Astrup et al. | Thrombelastographic patterns produced by fibrinolytic agents incorporated in fibrin | |
| Matsuo et al. | Effect of urinary trypsin inhibitor on osteoarthritis | |
| ES2072432T3 (es) | Activadores de plasminogenos fosforilados. | |
| Gurewich et al. | Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase) | |
| Hurlet-Jensen et al. | The release of Bβ 1–42 from fibrinogen and fibrin by plasmin | |
| Iwai et al. | Changes in mRNA levels of fibrinogen subunit polypeptides in rats defibrinogenated with batroxobin | |
| Åstedt et al. | Plasminogen activators in endometriosis | |
| Bjorlin et al. | Plasminogen activators in human xenografted oro-pharyngeal squamous cell carcinomas | |
| WO2025186634A8 (en) | Method and kit for monitoring anticoagulant therapy | |
| Jespersen | The venous occlusion test in fibrinolysis assays | |
| MATSUO et al. | The study of total antiplasmin activity | |
| AU4458289A (en) | A global test for measuring the principal components of the fibrinolysis system | |
| JPS56150356A (en) | Immunologic measuring method | |
| JPS6410173A (en) | Method for measuring blood fibrinolytic activity | |
| Prati et al. | Thrombin Modulation of Plasminogen Activator Inhibitor-1 (PAI-1) in Cultured Human Vascular Smooth Muscle Cells | |
| AU7618491A (en) | A method for the detection of plasminogen activators, their inhibitors or stimulators | |
| Godal et al. | Evidence that fibrin (ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |